Cargando…
CD40/CD40L and Related Signaling Pathways in Cardiovascular Health and Disease—The Pros and Cons for Cardioprotection
The CD40–CD40 ligand (CD40L) dyad represents a scientific and clinical field that has raised many controversies in the past and cannot be clearly defined as being an either beneficial or harmful pathway. Being crucially involved in physiological immunological processes as well as pathological inflam...
Autores principales: | Daub, Steffen, Lutgens, Esther, Münzel, Thomas, Daiber, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697597/ https://www.ncbi.nlm.nih.gov/pubmed/33198327 http://dx.doi.org/10.3390/ijms21228533 |
Ejemplares similares
-
Role of CD40(L)-TRAF signaling in inflammation and resolution—a double-edged sword
por: Strohm, Lea, et al.
Publicado: (2022) -
The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease
por: Bosmans, Laura A., et al.
Publicado: (2020) -
The CD40–CD40L Dyad in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
por: Aarts, Suzanne A. B. M., et al.
Publicado: (2017) -
CD40–CD40L in Neurological Disease
por: Ots, Heather D., et al.
Publicado: (2022) -
Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular disease
por: Lacy, Michael, et al.
Publicado: (2021)